| Kristy L Petersen, ARNP | |
|
540 The Rialto, Venice, FL 34285-2900 | |
| (941) 486-6927 | |
| (941) 486-6931 |
| Full Name | Kristy L Petersen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 540 The Rialto, Venice, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003313115 | NPI | - | NPPES |
| ARNP9335906 | Other | FL | ARNP LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LG0600X | Nurse Practitioner - Gerontology | ARNP9335906 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Summit Medical Center | Hermitage, TN | Hospital |
| Tristar Centennial Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alive Hospice, Inc | 0244276608 | 28 |
News Archive
A new risk prediction tool can identify patients at high risk of serious blood clots (known as venous thromboembolism) who might need preventative treatment, says a study published on bmj.com today.
Æterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it will make an oral presentation, as well as a poster presentation on Erk/PI3K inhibitor compounds, Tuesday, April 20, at the American Association for Cancer Research (AACR) Annual Meeting, to be held April 17-21, 2010 at the Walter E. Washington Convention Center in Washington, D.C.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the insurance industry, have again invested over $2 Million to support Anpac's "Cancer Differentiation Analysis" (CDA) technology.
The study, which appears in the December 18 online version of Cell Stem Cell and the January 2009 print edition of the journal, provides proof of principle that alternative sources of stem cells can be created.
Research conducted at Texas A&M University casts doubts on the notion that El Ni-o has been getting stronger because of global warming and raises interesting questions about the relationship between El Ni-o and a severe flu pandemic 91 years ago. The findings are based on analysis of the 1918 El Ni-o, which the new research shows to be one of the strongest of the 20th century.
› Verified 4 days ago
| Entity Name | Alive Hospice, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184682858 PECOS PAC ID: 0244276608 Enrollment ID: O20050707000451 |
News Archive
A new risk prediction tool can identify patients at high risk of serious blood clots (known as venous thromboembolism) who might need preventative treatment, says a study published on bmj.com today.
Æterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it will make an oral presentation, as well as a poster presentation on Erk/PI3K inhibitor compounds, Tuesday, April 20, at the American Association for Cancer Research (AACR) Annual Meeting, to be held April 17-21, 2010 at the Walter E. Washington Convention Center in Washington, D.C.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the insurance industry, have again invested over $2 Million to support Anpac's "Cancer Differentiation Analysis" (CDA) technology.
The study, which appears in the December 18 online version of Cell Stem Cell and the January 2009 print edition of the journal, provides proof of principle that alternative sources of stem cells can be created.
Research conducted at Texas A&M University casts doubts on the notion that El Ni-o has been getting stronger because of global warming and raises interesting questions about the relationship between El Ni-o and a severe flu pandemic 91 years ago. The findings are based on analysis of the 1918 El Ni-o, which the new research shows to be one of the strongest of the 20th century.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristy L Petersen, ARNP Po Box 850001, Orlando, FL 32885-0001 Ph: (941) 486-6927 | Kristy L Petersen, ARNP 540 The Rialto, Venice, FL 34285-2900 Ph: (941) 486-6927 |
News Archive
A new risk prediction tool can identify patients at high risk of serious blood clots (known as venous thromboembolism) who might need preventative treatment, says a study published on bmj.com today.
Æterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it will make an oral presentation, as well as a poster presentation on Erk/PI3K inhibitor compounds, Tuesday, April 20, at the American Association for Cancer Research (AACR) Annual Meeting, to be held April 17-21, 2010 at the Walter E. Washington Convention Center in Washington, D.C.
Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer Dr. Chris Yu announced that Venture Capital (VC) Firm, Shanghai Zhangjiang Science &Technology Investment Corporation (ZJSTIC), as well as private investors related to the insurance industry, have again invested over $2 Million to support Anpac's "Cancer Differentiation Analysis" (CDA) technology.
The study, which appears in the December 18 online version of Cell Stem Cell and the January 2009 print edition of the journal, provides proof of principle that alternative sources of stem cells can be created.
Research conducted at Texas A&M University casts doubts on the notion that El Ni-o has been getting stronger because of global warming and raises interesting questions about the relationship between El Ni-o and a severe flu pandemic 91 years ago. The findings are based on analysis of the 1918 El Ni-o, which the new research shows to be one of the strongest of the 20th century.
› Verified 4 days ago
Felicia Carnevale, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 517 Riviera St Ste D, Venice, FL 34285 Phone: 941-244-9524 Fax: 941-244-9526 | |
Destinee Renee Ogea, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8431 Pointe Loop Dr Fl 1, Venice, FL 34293 Phone: 941-207-5350 Fax: 941-207-5352 | |
Judy Humphreys, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1287 Us Highway 41byp S, Venice, FL 34237 Phone: 941-244-5706 Fax: 941-800-4342 | |
Ms. Kathryn S Collins, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1211 Jacaranda Blvd, Venice, FL 34292 Phone: 844-366-9362 | |
Agata Wawro, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 517 Riviera St Ste D, Venice, FL 34285 Phone: 941-244-9524 | |
Cynthia Beth Gamble, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 Nokomis Ave S Ste 207, Venice, FL 34285 Phone: 941-486-6790 Fax: 941-486-6795 |